logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
E

Expert Opinion on Pharmacotherapy

IF2.7
Papers119
Citations6801
Journal Papers 119
Publication Date
delete
Povorcitinib for Hidradenitis suppurativa: a narrative review on clinical trial data with expert commentary
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-07-03
delete0
PREAI
deleteKherallah, Kenan; Chung, Claire S.; Ontiveros, Sharon; Riley, Julia M.; Shi, Vivian Y.; Hsiao, Jennifer L.; Lee, Katrina H.
deleteShare
deleteSave
Is bacterial lysate add-on therapy a cost-effective strategy for childhood asthma? Evidence from a Colombian economic model
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-07-03
delete0
PREAI
deleteBuendia, Jefferson Antonio; Buendia Sanchez, Juan Antonio
deleteShare
deleteSave
Essential elements for guiding patient segmentation in precision pharmacotherapy for rheumatoid arthritis: lessons up to 2025
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-24
delete0
PREAI
deleteSonomoto, Koshiro; Tanaka, Yoshiya
deleteShare
deleteSave
The complexities of the pharmacotherapeutic management of chronic hepatitis C virus infection in hepatocellular carcinoma patients
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-24
delete0
PREAI
deleteSchiano Moriello, Nicola; Pinchera, Biagio; Gentile, Ivan
deleteShare
deleteSave
Targeted treatment of anemia in myelofibrosis and the impact of JAK inhibitors
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-24
delete0
PREAI
deleteAl Noumani, Iman; Harrison, Claire
deleteShare
deleteSave
Innovative approaches for managing relapsed or refractory peripheral T-cell lymphoma
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-03
delete0
PREAI
deleteGrainger, Brian T.; Casan, Joshua; Abeyakoon, Chathuri; Jain, Salvia; Prince, H. Miles
deleteShare
deleteSave
The challenges and practical considerations with optimizing neonatal pharmacotherapy
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-03
delete0
PREAI
deleteTurner, M. A.
deleteShare
deleteSave
Evaluating once-weekly insulin efsitora alfa for adults with type 2 diabetes
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-03
delete0
PREAI
deleteRamachandran, Akshaya; Batra, Jaskaran; Desouza, Cyrus
deleteShare
deleteSave
Targeted small molecules in polymyalgia rheumatica: the emerging role of JAK inhibitors beyond glucocorticoids and DMARDs
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-03
delete0
PREAI
deleteGonzalez-Gay, Miguel Angel; Alvarez-Rubio, Miguel; de Benito-Verniere, Ana; Belhaj-Gandar, Mariam; Roca-Magnet, Maria; Vicente-Rabaneda, Esther F.; Castaneda, Santos
deleteShare
deleteSave
Evaluating linaclotide for the treatment of functional constipation in children and adolescents
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-03
delete1
PREAI
deleteLinares, Manuel; Saps, Miguel
deleteShare
deleteSave
The impact of state-of-the-art pharmacotherapy for malaria in infants: a breakthrough?
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-05-03
delete0
PREAI
deleteGrobusch, Martin Peter; Adegbite, Bayode Romeo; Hanscheid, Thomas; Gupta, Nitin
deleteShare
deleteSave
New perspectives in managing chronic pelvic pain in endometriosis: the role of GnRH antagonists versus dienogest
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-04-13
delete1
PREAI
deletePalumbo, Mario; Giampaolino, Pierluigi; Pellicano, Massimiliano; Graziano, Vincenzo; Bifulco, Giuseppe; Della Corte, Luigi
deleteShare
deleteSave
Phenotypic response surface-guided pharmacotherapy for personalized combination treatment in complex diseases
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-04-13
delete2
PREAI
deleteKhan Khalil, Atif Ali; Saeed Akhtar, Muhammad; Zaman, Wajid; Amin, Adnan; Ali, Sajid
deleteShare
deleteSave
Emerging approaches to difficult-to-manage axial spondyloarthritis
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-04-13
delete0
deleteOAAI
deleteYuan-Dore, Jack Shi Jie; Yin, Lucia; Tahir, Syed Haider; Bamford, Sian; Tahir, Hasan
deleteShare
deleteSave
Pharmacotherapy options and drug development in bronchiectasis: spotlight on dipeptidyl-peptidase inhibitors
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-04-13
delete0
PREAI
deletePremuda, Chiara; Gramegna, Andrea; Misuraca, Sofia; Piedepalumbo, Federica; Terranova, Leonardo; Santambrogio, Martina; Contarini, Martina; Ori, Margherita; Blasi, Francesco
deleteShare
deleteSave
Pharmacotherapeutic landscape for the management of agitation associated with Alzheimer's disease
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-04-13
delete1
PREAI
deleteJain, Samir; Tunc, Ece Buyuksandalyaci; Grossberg, George T.
deleteShare
deleteSave
Is supplemental vitamin D useful in the clinically isolated syndrome (CIS) typical of multiple sclerosis?
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-04-13
delete0
PREAI
deleteDoggrell, Sheila A.
deleteShare
deleteSave
Thrombopoietin receptor agonists in immune thrombocytopenia: a comparative review of mechanisms, efficacy, and the future of personalized management
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-04-13
delete0
PREAI
deleteAndres, Emmanuel; Jannot, Xavier; Terrade, Jean Edouard; Lorenzo-Villalba, Noel
deleteShare
deleteSave
Evaluation of novel treatments for metastatic castration-resistant prostate cancer
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-04-01
delete0
PREAI
deleteGuner, Gurkan; Arslan, Cagatay
deleteShare
deleteSave
Clinical positioning and future prospects of JAK inhibitors in alopecia areata
deleteExpert Opinion on Pharmacotherapy
IF2.7
delete2026-04-01
delete0
PREAI
deleteWada-Irimada, Moyuka; Takahashi, Takehiro; Asano, Yoshihide
deleteShare
deleteSave